Makary Resigns as FDA Commissioner
He leaves after pressure from industry, anti-abortion activists and White House allies over drug reviews, flavored vapes and abortion pill policy.
- On Tuesday, FDA Commissioner Marty Makary stepped down after 13 months leading the agency, with Kyle Diamantas expected to serve as acting commissioner following a decision by Health and Human Services Secretary Robert F. Kennedy Jr. and White House approval.
- Makary's tenure faced months of internal turmoil marked by sweeping layoffs, turnover among senior leadership, and repeated clashes with lawmakers and the pharmaceutical industry over his handling of mifepristone and flavored vapes.
- Last Tuesday, the FDA authorized fruit-flavored vapes fulfilling a 2024 campaign promise, while the Supreme Court recently allowed nationwide mifepristone access despite Republicans continuing to push for reversals of telehealth dispensing rules.
- This departure marks the administration's fourth high-profile exit this year, following Labor Secretary Lori Chavez DeRemer's April resignation and the removal since January of Homeland Security Secretary Kristi Noem and Attorney General Pam Bondi.
- Regulatory uncertainty now surrounds the FDA's enforcement priorities, as the agency has not released its review of abortion pills—a process Makary reportedly asked officials to delay until after the midterms.
359 Articles
359 Articles
HHS Is A Chaos Engine: Marty Makary Out At FDA
We've complained a great deal about RFK Jr.'s stint running HHS and its effects on the health of Americans in the short and long term because, well, there's a lot to complain about. His anti-vaxxer stances have begun infecting national vaccine policy, of course, and his stance of essentially ignoring an ongoing 17 month measles…
FDA chief Marty Makary steps down after clashes with White House over vapes, abortion pill, and agency direction
Food and Drug Administration Commissioner Marty Makary resigned Tuesday after roughly 13 months in office, ending a tenure marked by policy reversals, friction with senior administration officials, and mounting complaints from pharmaceutical executives, vaping lobbyists, and pro-life groups alike. President Trump confirmed the departure on Truth Social and named Kyle Diamantas, the FDA’s deputy commissioner...
Trump’s FDA Chief Is Pushed Out. Acting Head Is Nonscientist Friend of Don Jr.
Trump’s commissioner of the Food and Drug Administration, Dr. Martin Makary, has resigned. During Makary’s 13-month tenure, he attempted to split the difference between Health and Human Services Secretary Robert F. Kennedy Jr.’s Make America Healthy Again agenda and a more traditional approach to regulation, ultimately angering both camps. “Nobody was happy with what he did,” says Dr. Source
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
